Trial Profile
An Observational Study of South African Dialysis Patients Treated With Aranesp
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Amgen
- 09 Apr 2014 According to the ClinicalTrials.gov record, status changed from recruiting to discontinued.
- 24 Oct 2013 New trial record